Author argues UiPath is a real value investment with GAAP profitability, $1.5B cash, no debt, 16% revenue growth, 85% gross margins, and a pivot to Agentic AI in financial crime and healthcare, trading at a discount.
PATH — LONG Author argues UiPath is undervalued after a 40%+ dump despite being GAAP profitable, holding over $1.5 billion in cash with no debt, 16% revenue growth, and 85% gross margins. The company is pivoting to Agentic AI in sticky sectors like financial crime and healthcare, with analysts' average price target of $16.20 and forward PE of 16. C-suite has purchased over $800M since 2023. Main risk is that the SaaS selloff continues or the pivot fails to gain traction.
UIPath is engrained in the agentic AI market and will be better off because of it. This company has one of the best balance sheets for its size and market and is a huge discount right now.
This Reddit post, published February 24, 2026, features u/yddilyddil discussing PATH. 1 trade idea extracted by AI with direction and confidence scoring.
Speakers: u/yddilyddil · Tickers: PATH